licensing agreement
Immunovia, JW BioScience Ink Licensing Agreement for Early Pancreatic Cancer Detection Biomarkers
Immunovia said that it has secured intellectual property rights to the biomarkers, which are part of the diagnostic signature for its Immray PanCan-d blood test.
ERS Genomics Licenses CRISPR-Cas9 Portfolio to Cellular Engineering Technologies
CET said it will integrate its stem cell technology with CRISPR-Cas9 to create next-generation stem cells for life science research.
ERS Genomics Licenses CRISPR IP to Japan SLC
Japan SLC, a biotechnology company providing animal models to the research community, will use the license to expand its offerings.
ERS Genomics Licenses CRISPR IP to Nippon Gene
Nippon Gene, a biotechnology company based in Japan, will use the license to develop, manufacture, and sell research reagents using CRISPR-Cas9 technology.
ERS Genomics Licenses CRISPR IP to GenOway
ERS Genomics was founded to provide access to CRISPR-Cas9 intellectual property shared by Emmanuelle Charpentier, Jennifer Doudna, and others.
Apr 19, 2021
ERS Genomics Licenses CRISPR Patents to Nuvisan
Mar 10, 2021
ERS Genomics Licenses CRISPR Patents to Setsuro Tech
Feb 4, 2021